seed
Stage
1
Investors
About
OP2 Drugs is a biotech company developing innovative small molecule drugs. They target the Opioid Peptide System to treat severe diseases with high unmet medical needs, including pain and inflammation.
Explore OP2 Drugs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.